Our Perspectives
THREAD Blog
Three Keys To Building Effective AI-Driven Products
Artificial intelligence, while already at work in many applications, remains a mystery and even a buzz term for many working in technology. AI will only continue to evolve, and its use will increase. For companies developing products that will utilize AI, it is critical to have clear objectives.
Combining Patient-Centric Technology and RWD for Comprehensive Evidence
Digital technologies that have primarily been used to decentralize clinical trials can be used to optimize the capture and curation of certain types of real world data (RWD) from patients.
Navigating the Changes to the EU Clinical Trials Regulations 536/2014 – Managing the Application and Authorisation Process
The processes for applying for and authorizing clinical trials in Europe have, traditionally, held numerous inefficiencies. Currently governed under the Clinical Trial Directive 2001/20/EC, trial sponsors have been required to submit separate applications for each member state in the European Economic Area (EEA) where they planned to conduct a study.
How to Scale Successful Decentralized Clinical Trials
When evaluating how to maximize trial success, especially given the growth of DCT methodology, scaling studies on a global level provides significant opportunity to enhance health outcomes and improve study timelines in the life sciences industry.
3 Ways that Technology Can Help Make Clinical Trials More Representative
Representation in clinical trials is a hot topic. The historical lack of representativeness and diversity in research came to greater attention recently as the world raced to develop safe vaccines that would work for everyone. Healthcare and political leaders needed to ensure that they could say with confidence that the resulting vaccines would work for everyone…